Pathogenic bacterium in vagina

The term "Pathogenic bacteria in vagina" does not refer to a specific molecular target or receptor but rather describes a diverse group of anaerobic and facultative anaerobic bacterial species that can overgrow in the vagina and disrupt the normal balance of the vaginal microbiota. The most common clinical manifestation associated with these organisms is bacterial vaginosis, which results from an imbalance where beneficial lactobacilli are outnumbered by potentially harmful species such as Gardnerella vaginalis, Atopobium vaginae, Mobiluncus spp., and others[1][5]. These bacteria are not considered therapeutic targets in the sense used for drug development against receptors or enzymes; instead, they represent infectious agents treated broadly with antibiotics. Bacterial vaginosis increases susceptibility to other infections including sexually transmitted infections and can cause complications during pregnancy if left untreated[1][5]. Diagnosis relies on clinical criteria including characteristic discharge, elevated pH, presence of clue cells under microscopy, and fishy odor. Treatment involves antibiotics such as metronidazole or clindamycin administered orally or intravaginally; recurrence rates are high even after successful therapy[3][4]. Because "Pathogenic bacteria in vagina" is not a single molecule but rather an umbrella term for various microorganisms implicated in disease states like bacterial vaginosis—and because it lacks specificity regarding molecular structure or function—it should not be classified as a canonical drug target.

Other names

Bacterial vaginosis-causing bacteriaVaginal pathogenic bacteriaBV-associated bacteriaAnaerobic vaginal pathogens

Inhibition of bacterial DNA synthesis (metronidazole, secnidazole); Inhibition of bacterial protein synthesis (clindamycin)